In this post, we summarize noteworthy False Claims Act (FCA) decisions from the second quarter of 2023.
Continue Reading False Claims Act Decisions to Know from Q2 2023False Claims Act Fundamentals: How to Respond to a Third-Party Subpoena
By Hannah Webber on
Posted in Discovery, FCA Fundamentals
If you are part of a heavily regulated—or heavily litigated—industry, at some point, you or your company are likely to receive a third-party subpoena.
Continue Reading False Claims Act Fundamentals: How to Respond to a Third-Party SubpoenaRegister Now: The Supreme Court and the False Claims Act Webinar Replay
By Matt Curley, Lisa Rivera & Brian Roark on
The Supreme Court recently released important opinions that will shape False Claims Act investigations and litigation for years to come.
Continue Reading Register Now: The Supreme Court and the False Claims Act Webinar ReplayMartin’s Point Health Care Inc.’s $22.4M Settlement Illustrates DOJ’s Focus on Part C Fraud
By Emily Farmer & Lindsey Fetzer on
Last week, the U.S. Department of Justice (DOJ) announced a $22.4 million settlement resolving allegations that Martin’s Point Health Care, Inc. (Martin’s Point) violated the False Claims Act (FCA) by submitting inaccurate diagnosis codes for its Medicare Advantage Plan enrollees.
Continue Reading Martin’s Point Health Care Inc.’s $22.4M Settlement Illustrates DOJ’s Focus on Part C FraudExpect More Cyber-Enforcement under the False Claims Act
By Taylor Sample on
Earlier this month, the White House released the National Cybersecurity Strategy Implementation Plan outlining specific “high impact initiatives” that the federal government will carry out to achieve its cybersecurity objectives.
Continue Reading Expect More Cyber-Enforcement under the False Claims ActCMS Publishes New Data on Self-Referral Disclosure Protocol Settlements
By Travis Lloyd, Kristin Bohl & Justin Brown on
The Centers for Medicare & Medicaid Services (CMS) recently published updated data regarding settlements made under the Voluntary Self-Referral Disclosure Protocol (SRDP), an important mechanism through which providers may disclose actual or potential violations of the federal physician self-referral prohibition commonly known as the Stark Law.
Continue Reading CMS Publishes New Data on Self-Referral Disclosure Protocol SettlementsFalse Claims Act Settlements to Know from Q2 2023
By Bass, Berry & Sims on
There have been several noteworthy False Claims Act (FCA) settlements in the second quarter of 2023.
Continue Reading False Claims Act Settlements to Know from Q2 2023Controlled Substances Act and False Claims Act Collide
By Garrah Carter-Mason & Brian Irving on
The United States recently intervened in a False Claims Act lawsuit accusing Rite Aid of defrauding federal healthcare programs by seeking reimbursement for opioids the pharmacy allegedly dispensed in violation of the Controlled Substances Act.
Continue Reading Controlled Substances Act and False Claims Act CollideGovernment Scrutiny of COVID-19 Relief Funds
By Brian Irving & Hannah Choate on
Posted in COVID-19, Enforcement
We authored an article published in the June 2023 issue of the American Bar Association’s (ABA) Health Lawyer addressing government scrutiny of COVID-19 relief funds.
Continue Reading Government Scrutiny of COVID-19 Relief FundsSupreme Court Upholds Broad Government Authority to Dismiss Qui Tam False Claims Act Lawsuits
By Brian Irving on
On June 16, the U.S. Supreme Court issued its opinion in U.S. ex rel. Polansky v. Executive Health Resources, a closely watched case about the government’s power to dismiss a False Claims Act (FCA) qui tam lawsuit over a relator’s objection.
Continue Reading Supreme Court Upholds Broad Government Authority to Dismiss Qui Tam False Claims Act Lawsuits